Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (1): 116-120    DOI: 10.31083/j.ejgo.2020.01.4868
Case Report Previous articles | Next articles
Efficacy of multimodality therapy for patients with large-sized locally advanced breast cancer - a retrospective analysis of 17 cases
J. Song1, J. Ma1, X. Qi1, *()
1 Department of Galactophore, The Seventh Medicanl Center of PLA general Hosptital, Beijing, China
Download:  PDF(665KB)  ( 246 ) Full text   ( 5 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
The objective of this study was to explore the clinical significance of multimodality therapy for huge-sized locally advanced breast cancer (LABC) in a retrospective analysis of 17 patients with large-sized locally advanced breast cancer. The mean tumor size was 11.5×10.1 cm. Among these 17 patients, three (17.6%) cases developed clinical evidence of distant metastases (liver, lung, bone, etc.), ten cases (58.8%) had skin ulcers, and discharges with a peculiar smell. The patients underwent TEC/AT chemotherapy, interventional therapy, and Ad-p53 gene therapy. All treatments were well-tolerated and 15 (88.2%) cases of the patient underwent standard or modified radical mastectomy successfully. The other two patients, who di not undergo surgical treatment because of metastases and other reasons, were treated with endocrine therapy. Until now, the average survival time has reached 31.5 months. In treating large-sized locally advanced breast cancer, multimodal therapies are able to diminish the burthen of the tumor, lower the clinical stage, and increase resection rate of cancer, thus improving survival rates and quality of life for patients.
Key words:  LABC      Multimodality therapy      Ad-p53 gene therapy      Interventional therapy     
Published:  15 February 2020     
*Corresponding Author(s):  XIAODONG QI     E-mail:  drqxd@163.com

Cite this article: 

J. Song, J. Ma, X. Qi. Efficacy of multimodality therapy for patients with large-sized locally advanced breast cancer - a retrospective analysis of 17 cases. European Journal of Gynaecological Oncology, 2020, 41(1): 116-120.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.01.4868     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I1/116

No related articles found!
No Suggested Reading articles found!